Duration and Quality of 1% Ropivacaine Ankle Blocks

NCT07078396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2025-07-22

No results posted yet for this study

Summary

The goal of this observational study is to determine the analgesic duration and analgesic quality of a 1% ropivacaine ankle block in forefoot surgery. Bilateral cases of forefoot surgery, preoperative use of steroids, preexisting lower extremity neuropathy, or failed blocks were not included in this quality improvement program.

An ankle block with 1% ropivcaine and patient follow-up is part of the standard practice at Ziekenhuis Oost-Limburg.

Conditions

  • Forefoot Surgery

Sponsors & Collaborators

  • Ziekenhuis Oost-Limburg

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-04-24
Completion
2024-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07078396 on ClinicalTrials.gov